Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • waseem
    replied
    m 1, as I understood will give you the reads that map to only 1 location. (unique reads). My approach is, these reads are counted as true counts (given more weights). The reads mapping at multiple locations might be separated into reads mapping at alternatively spliced variants (different variants of same gene models) and the reads mapping to different genes (multi reads). I am working on separating these reads and counting them with different weights.

    Leave a comment:


  • frymor
    started a topic bowtie -m option

    bowtie -m option

    Hi everybody,

    maybe I misunderstood it completely, but what is the option -m good for?
    If I am looking for differentially regulated genes in my data set and i set a high m-value (lets say 5), I know there are for some reads up to five different possible locations which they can be matched.

    @what exactly does it mean for my data?

    Do I have my read at different positions on the reference genome?
    This way my data for differentially expressed genes will be biased.
    Do I have these reads at five locations or there is just one, best location where it mapped to.

    I have pair-end data set, so I can't use the best and strata combination.
    @What I don't exactly understand is the definition of uniqueness in the bowtie -m option?

    If I use the option -m 1 I will loose a large part of my data, so I don't want to do it, but I would like to see, that the reads are mapped are as specific as possible.
    the command I use to run bowtie is as such:
    bowtie -a -m 5 -n 2 -l 22 -q --un total_trimmed.unmapped -t -p 2 -5 11 --chunkmbs 256 --max total_5trimmed.maxHits -S d_melanogaster_fb5_32 -1 s2_1_sequence.fq -2 s2_2_sequence.fq total_5trimmed.sam

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
52 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...